Femtech Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

The Femtech Market Size is Segmented by Type (Products, Software, Services), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness), By End-use (Direct-to-consumer, Hospitals, Fertility Clinics, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments

Market Snapshot

Femtech Market Size
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 12.1 %
Femtech Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The femtech market is expected to register a CAGR of 12.1% during the forecast period.

During pandemic, women faced several health conditions due to changed lifestyle habits, mental health issues, increased risk of developing metabolic syndrome and other chronic diseases. As per the research article published by the Startup Health in January 2020, the rapid spread of the COVID-19 pandemic had both a direct and indirect impact on health outcomes for mothers and their babies. Start-up companies such as Lactation Lab and Robyn started offering accessible and affordable resources that can improve maternal healthcare access and availability, especially in low- and middle-income communities. According to an article published by the Lancet Global Health in 2021, studies from South Africa explained the impact of the first wave of COVID-19 on maternal and reproductive health services and maternal mortality. The study showed that there had been an increase of 30% in maternal deaths since lockdown started and the pandemic peaked in 2020, as compared with data during the same period in 2019. In pregnant women, there was an increase in cases such as miscarriages, stillbirths, and birth complications cases, which led to anxiety, depression and hormonal imbalance. With growing health concerns during the pandemic, industry leaders increased their focus on developing innovative software, services and products with the aim to provide their products and solutions in remote areas across the world which is expected to increased demand for femtech market.

There is an increase in focus of investors to provide funding for solutions related to women's health and well-being is expected to boost the market growth. According to the research article published by Fierce Healthcare digital health startups focused on women’s health care earned $1.3 billions in 2021. In addition, increased demand for reproductive health, overall increasing demand for digital health solutions, promoting women's sense of self-worth, product innovations are the major driving factors rising the femtech market. On the other side, increase in lifestyle diseases and chronic disorders in women is also expected to increase the femtech market. Such factors are expected to boost the market growth during the forecast period.

Scope of the Report

As per the scope of the report, femtech includes the devices and solutions that help empower women’s health and well-being. These devices and solutions can be used for various applications related to reproductive systems, fertility disorders, pregnancy and other women-related healthcare issues. The Femtech Market Size is segmented By Type (Products, Software, Services), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness), By End-use (Direct-to-consumer, Hospitals, Fertility Clinics, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Reproductive health is Expected to dominate the market over the forecast period

There is current trend among the women to become pregnant at a later age owing to increased focus on career and late marriage . Many factors such as older women’s age and environmental factors contributes to increase in number of women experiencing trouble before, during, or after pregnancy, and therefore the demand of femtech solutions for reproductive health is expected to grow. According to an article by the Blue Cross Blue Shield Association, around seven out of every 1,000 pregnant women had experienced pregnancy and childbirth complications in 2018, almost 31% increase as compared to data in 2014. The increase in investment towards reproductive health related apps and devices is also expected to propel the market growth. For instance, as per the data by the Australia based femtech digital health companies, around 3% of the investment deals focused on women's health companies. 

Factors such as data privacy is expected to restraint the adaptation of femtech market. According to the research article ,published in the Journal of Internal Medical Research in May 2022, the study found that 20 out of 23 apps shared data with third parties in which only 16 displayed as privacy policy. For instance, Flo ovulation app had almost 100 million users, whose data were shared with third party companies. 

Femtech Market Trends

North America Expected to Record the Largest Share During the Forecast Period

North America accounted for the largest share in the global femtech market due to the high prevalence of cancer among women, rising incidence of lifestyle-related disorders, high adoption of technologically advanced products, product launches, and government initiatives. According to the Centers for Disease Control and Prevention (CDC), over 15.6% of women over the age of 18 suffer from poor health conditions. 

The presence of better healthcare infrastructure, growing awareness about women’s health disorders, and increased participation by women in the workforce are poised to positively influence the regional market’s growth. The increase in the investments among femtech companies based in the North American region will help to boost the market growth in the region. For instance, in April 2022, Conceive received USD 3.7 million funding that would be used for its outcomes-oriented fertility solution. Such investments would help to propel the market demand in the region.

Femtech Market Analysis

Competitive Landscape

The market has a large number of companies that are significantly contributing to the market growth. Some major players are Hera MED, Toto health, Sustain Natural, Nuvo, Athena Feminine Technologies, Minerva, Isono Health, Sera Prognostics, Bio Wink, and Elvie. New product developments, New applications, and acquisitions are some of the strategies being undertaken by these companies to strengthen their market presence.

Recent Development

  • In April 2022, Conceive received USD 3.7 million funding that would be used for its outcomes-oriented fertility solution
  • In June 2022, OCON Healthcare received FDA acceptance of IND application for its patented IUBTM (Intra-Uterine Ball) platform.

Table of Contents


    1. 1.1 Study Assumptions & Market Defination

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in adoption of digital health solution

      2. 4.2.2 Advancement in artificial intelligence and virtual assistance

      3. 4.2.3 Growth in investments and funding in femtech industry

    3. 4.3 Market Restaints

      1. 4.3.1 Lack of awareness about femtech products and applications in developing nations

      2. 4.3.2 Cybersecurity and privacy concerns

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type

      1. 5.1.1 Product

      2. 5.1.2 Software

      3. 5.1.3 Services

    2. 5.2 By Application

      1. 5.2.1 Reproductive health

      2. 5.2.2 Pregnancy & Nursing care

      3. 5.2.3 Pelvic & Uterine healthcare

      4. 5.2.4 General Healthcare & Wellness

      5. 5.2.5 Others

    3. 5.3 By End Use

      1. 5.3.1 Direct to Customer

      2. 5.3.2 Hospitals

      3. 5.3.3 Fertility Clinics

      4. 5.3.4 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 HeraMED

      2. 6.1.2 Nuvo Cares

      3. 6.1.3 Elvie

      4. 6.1.4 HeraMED

      5. 6.1.5 Flo Health, Inc.

      6. 6.1.6 Natural Cycles USA Corp

      7. 6.1.7 iSono Health

      8. 6.1.8 BioWink GmbH

      9. 6.1.9 Sera Prognostics

      10. 6.1.10 Athena Feminine Technologies

    2. *List Not Exhaustive

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Femtech Market market is studied from 2019 - 2027.

The Femtech Market is growing at a CAGR of 12.1% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

HeraMED, Sera Prognostics, iSono Health, Flo Health, Inc., Elvie are the major companies operating in Femtech Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!